A long time History of Research

Although probiotics have only recently become a popular topic with the public, at Morinaga we have been researching them for over 40 years!

Here is a timeline of significant events in the research of Bifidobacterium longum BB536:

Timeline of Bifidobacterium longum BB536 Research

1969

BB536 first isolates from healthy infant

1977

Morinaga milk supplements with BB536 available for retail sale

1978

Research demonstrates improvement in regularity and fecal microflora of elderly subjects

Read More

1979

Morinaga yogurt product with BB536 launches for retail sale

1984

Morinaga receives award from the Japanese Science & Technology Agency for tge "Application of BB536 to dairy products"

1986

Licensed production Morinaga Bifidus Yogurt begins in France and receives award from French Ministry of Agriculture

1988

Study investigates effects of BB536 on leukemia patients (Effects of BB536 on Candida infection)

Read More

1994

Research investigates the effects of BB536 on development of bifidobacteria flora in premature infants

Read More

1996

Morinaga BB536 Yogurt is awarded by the Japanese Ministry of Health with FOSHU status (Food for Special Health Use)

1997

Morinaga research shows relationship between BB536 and improvement of microflora balance and regularity (Gastrointestinal Health - GI)

Read More

2001

BB536 is applied to constipation case; continuous research of BB536's effects if Gi health

Read More

2003

Research investigates effects of BB536 on survival rates of mice infected with E. coli O157

Read More

2009

Bifidobacterium longum BB536 is awarded GRAS status by the FDA

2013

JSBBA Award for Achievement in Technological Research

2014

More than 100 articles published for BB536

1978

Study# 4: The effect of Bifidobacterium cultured milk on the "Regularity" among on aged group

< Publication; Journal of Japanese Society of Nutrition and Food Science 31(4) : 379-387 (1978) >

1988

Study# 6: Intestinal Candida overgrowth and Candida infection in patients with leukemia : Effect of Bifidobacterium administration.

< Publicatoin; Bifidobacteria Microflora 7(2) : 71-74 (1988) >

1994

Study #12: Akiyama K, et al., Effects of Administration of Bifidobacterium in extremely premature infants: Development of intestinal microflora by orally administered Bifidobacterium longum (in comparison with Bifidobacterium breve)

< Publication: Acta Neonatologica Japonica 30, 257-263. (1994) >

1997

Study# 1: Effect of Bifidobacterium longum BB536 administration on the intestinal environment, defecation frequency and fecal characteristics of human volunteers

< Publication; Bioscience Microflora 16(2) : 53-58 (1997) > 


Study # 2: Effect of yogurt containing Bifidobacterium longum BB536 on the intestinal environment, fecal characteristics and defecation frequency: A comparison with standard yogurt

< Publication; Bioscience Microflora 16(2) : 73-77 (1997) >

2001

Study# 35: Effect of non-fermented milk containing Bifidobacterium longum BB536 on the defecation frequency and fecal characteristics in healthy adults

< Publication; Journal of Nutritional Food 4(2) : 1-6 (2001) >

View investigations of Bifidobacterium longum BB536 (Clinical Study)

2003

Study #36: Namba K, et al., Inhibitory effects of Bifidobacterium longum on enterohemorrhagic Escherichia coli O157:H7

< Publication: Bioscience Microflora 22 (3): 85-91 (2003) >